NCT07696572Recruiting
EUS Procedures Using RIVOS™ EUS Access Device
Registry of Patients Undergoing Endoscopic Ultrasound (EUS) Procedures Using the RIVOS™ EUS Access Device
Source: ClinicalTrials.gov · Last updated 20 Oct 2026
Brief summary (registry, in English)
This is a prospective study of patients undergoing EUS procedures using the RIVOS™ EUS access device.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 30 (estimated)
- First submitted
- 6 Jul 2026
- Start date
- 13 Jul 2026
- Primary completion date
- 31 Jul 2027
- Lead sponsor
- Orlando Health, Inc.
- Diseases
- Pancreatic cancer
- NCT number
- NCT07696572
What you commit to
- Study type: Observational
- Planned participants: 30
- From 13 Jul 2026 to the primary completion date, 31 Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age \< 18 years
Other
- Patients who did not undergo EUS-guided interventions using the RIVOS™ EUS access device
Who the study is looking for
- Age ≥ 18 years
- All patients undergoing EUS-guided interventions using the RIVOS™ EUS access device
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Orlando Health Digestive Health Institute Coordinator of this site? Confirm its status | Orlando | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.